Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

612.22 +65.48 (+11.98%)
Streaming Delayed Price Updated: 12:02 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins
Medpace shares climb as Q3 earnings and revenue top estimates, driven by strong bookings, rising backlog, and an upbeat 2025 guidance. 
Via Benzinga
Topics Earnings
Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Stock Market Today: Dow Jones, Nasdaq Futures Tumble Amid US-China Trade Tensions—Tesla, IBM, American Airlines In Focus
U.S. stock futures were swinging on Thursday following Wednesday’s declines. Futures of major benchmark indices were lower. 
Via Benzinga
Topics Stocks
Preview: Medpace Hldgs's Earnings
 
Via Benzinga
MEDPACE HOLDINGS INC (NASDAQ:MEDP) Emerges as a Top Growth and Momentum Pick
MEDP Holdings stock shows strong technical and fundamental growth momentum, meeting strict trend-following criteria for a powerful setup. 
Via Chartmill
Medpace Rockets On 'Another Strong Q' That Includes A Guidance Hike
Medpace stock rocketed late Wednesday on "another strong Q," that included double-digit sales and profit growth. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Medpace Holdings Inc (NASDAQ:MEDP) Tops Q3 2025 Earnings and Revenue Estimates
Medpace (MEDP) Q3 2025 earnings beat analyst forecasts with strong revenue and EPS growth. The CRO also reported robust bookings and raised its full-year guidance. 
Via Chartmill
Topics Earnings
Medpace (NASDAQ:MEDP) Beats Q3 Sales Expectations, Stock Jumps 18.5%
Clinical research company Medpace Holdings (NASDAQ:MEDP) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 23.7% year on year to $659.9 million. The company’s... 
Via StockStory
Which stocks are moving after the closing bell on Wednesday?
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
Medpace (MEDP) Reports Earnings Tomorrow: What To Expect
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results this Wednesday afternoon. Here’s what to expect. 
Via StockStory
1 High-Flying Stock to Research Further and 2 That Underwhelm
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,... 
Via StockStory
Topics Supply Chain
1 Volatile Stock Worth Investigating and 2 That Underwhelm
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
Earnings Scheduled For October 22, 2025
 
Via Benzinga
Medpace and Revvity Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
3 Market-Beating Stocks with Competitive Advantages
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
Via StockStory
Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
This RH Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
 
Via Benzinga
Why Medpace (MEDP) Stock Is Trading Lower Today
Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 3.2% in the morning session after Barclays downgraded the stock to "Underweight" from "Equal-Weight" and reduced its price... 
Via StockStory
Breaking Down Medpace Hldgs: 10 Analysts Share Their Views
 
Via Benzinga
1 Healthcare Stock with Exciting Potential and 2 We Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This... 
Via StockStory
Topics Stocks
2 Profitable Stocks with Exciting Potential and 1 We Turn Down
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Topics Regulatory Compliance
Medpace Hldgs Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
 
Via Benzinga
This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
 
Via Benzinga
2 Mooning Stocks to Target This Week and 1 That Underwhelm
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
2 Cash-Producing Stocks on Our Watchlist and 1 We Turn Down
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
2 Reasons to Watch MEDP and 1 to Stay Cautious
Medpace currently trades at $450.01 and has been a dream stock for shareholders. It’s returned 266% since August 2020, more than tripling the S&P 500’s 85.3% gain. The company has also beaten the index... 
Via StockStory
Topics Stocks Supply Chain
3 Market-Beating Stocks with Competitive Advantages
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the... 
Via StockStory
Why Medpace (MEDP) Stock Is Trading Lower Today
Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 3.3% in the morning session after UBS downgraded the stock to 'Sell' from 'Neutral', sending shares lower. The investment bank... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.